The effect of a human recombinant hybrid alpha interferon (referred to as rHulFN-alphaA/D) on pulmonary metastases induced by intravenous injection of B16 FIO melanoma cells in C57BU6 mice was examined; rHulFN-alphaAID has been previously shown to have anti-viral, anti-proliferative and immunomodula
Action of recombinant alpha interferon against experimental and spontaneous metastases in a murine model
โ Scribed by P. Ramani; F. R. Balkwill
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 675 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
The therapeutic potential of rHulFN-a A/D, a hybrid human IFN molecule with equal activity on murine cells, was studied in experimental and spontaneous metastatic models of a murine colon carcinoma COLON 26. rHulFN-a! A/D inhibited experimental pulmonary metastases of COLON 26 and prolonged the survival of BALB/c mice. Dose scheduling, survival and tumour-cell clearance studies showed that the first 5 days were critical in the inhibition of pulmonary metastases. However, it is unlikely that lung N K cells were involved in the anti-metastatic effect of rHulFN-a AID because inhibition of pulmonary metastases and a decrease in radio-labelled tumour-cell survival was seen in BALBlc mice depleted selectively of their NK cells by prior treatment with rabbit anti-asialoGM, serum. Although rHuIFN-a A/D stimulated NK-cell activity in BALB/c mice, it was ineffective in abrogating the NK suppressant action of rabbit anti-asialoGMl serum on murine lung NK cells. Thus, IFN may mediate its early antimetastatic effect via a mechanism independent of NK-cell stimulation. IFN also inhibited the development of lung metastases from S.C. COLON 26 tumours in normal, NK-depleted and T-cell-deficient mice.
๐ SIMILAR VOLUMES
The in vivo anti-tumor activity of 2 recombinant cytokines, interleukin-2 (rlL-2) and human hybrid interferon alpha (rHulFN-aA/D), were tested using the murine reticulum cell sarcoma M5076. Experimental hepatic metastases, following i.v. injection of tumor cells, and tumor growth and spontaneous met
Anti-tumor effects of TNF in animal models are well documented. Therapeutic use of TNF, however, is hampered by its toxicity. In rats a single intravenous (i.v.) injection of 40 pg/kg is lethal. When given by continuous i.v. infusion, much higher doses are well tolerated. To compare the therapeutic